Stephanie; id_orcid 0000-0002-9441-5535 Shoop-Worrall

Outcomes in JIA have greatly improved, but we can still do better

Abstract Outcomes for children and adolescents with juvenile idiopathic arthritis (JIA) have improved substantially over the past two decades, driven by biologic and targeted synthetic DMARDs, treat-to-target strategies with regular standardized assessments, and multidisciplinary...

Challenges in linking interferon signatures to clinical trajectories in juvenile idiopathic arthritis

Abstract Background Based on the recent finding that higher baseline expression of interferon (IFN)-driven gene signature in blood positively correlates with good response to methotrexate (MTX) in Juvenile Idiopathic Arthritis (JIA), this study tested the hypothesis that baseline...